CRYOPORT, INC. Acquisitions, Net of Cash Acquired
CRYOPORT, INC. (CYRX) reported Acquisitions, Net of Cash Acquired of $313.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-03-05
- CRYOPORT, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2024-12-31 was $18.00K.
- CRYOPORT, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2021-12-31 was $500.00K.
- CRYOPORT, INC. payments to acquire businesses, net of cash acquired for fiscal 2024 was $313.00K, a 95.74% decline from fiscal 2023.
- CRYOPORT, INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $7.34M, a 12.01% increase from fiscal 2022.
- CRYOPORT, INC. payments to acquire businesses, net of cash acquired for fiscal 2022 was $6.55M, a 18.30% increase from fiscal 2021.
- CRYOPORT, INC. payments to acquire businesses, net of cash acquired for fiscal 2021 was $5.54M, a 98.47% decline from fiscal 2020.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|
| 2024-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $313.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $295.00K 10-Q · filed 2025-11-06 | ||
| 2023-12-31 | $7.34M 10-K · filed 2026-03-05 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $6.55M 10-K · filed 2025-03-07 | |
| 2022-09-30 | $6.55M 10-Q · filed 2022-11-04 | ||
| 2021-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $5.54M 10-K · filed 2024-03-13 | |
| 2021-09-30 | $5.04M 10-Q · filed 2022-11-04 | ||
| 2020-12-31 | $363.14M 10-K · filed 2023-02-28 | ||
| 2019-12-31 | $20.32M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |